A Case Report of Percutaneous Right Ventricular Assist Device Utilization After Cesarean Delivery in a Patient With Severe Pulmonary Arterial Hypertension

A A Pract. 2023 Nov 17;17(11):e01728. doi: 10.1213/XAA.0000000000001728. eCollection 2023 Nov 1.

Abstract

Physiologic changes of pregnancy are poorly tolerated in patients with pulmonary arterial hypertension (PAH), and peripartum maternal mortality is high. We present a case of a 31-year-old G3P0020 patient at 35 weeks' gestation with severe World Health Organization group I PAH who underwent cesarean delivery followed by percutaneous right ventricular assist device placement. Risks and benefits of the mode of delivery, neuraxial versus general anesthesia, and mechanical circulatory support are reviewed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cesarean Section
  • Familial Primary Pulmonary Hypertension
  • Female
  • Heart-Assist Devices*
  • Humans
  • Hypertension, Pulmonary* / therapy
  • Pregnancy
  • Pulmonary Arterial Hypertension* / therapy